INS and hyperinsulinism: Animal models with reduced plasma IGF-1 show increased circulating GH, leading to hyperinsulinemia, lower insulin sensitivity, and impaired carbohydrate metabolism (Yakar et al., 2001; Yakar et al., 2004)